Global Drug Screening Market Size, Trends, & Growth, Opportunity, By Product and service (Drug Screening Product, Analytical Instruments, Rapid Testing Devices, Oral Fluid Testing Devices, Consumables, Drug Screening Service), By Sample Type (Urine Samples, Breath Samples, Fluid Samples, Hair Samples, Other), By End User (Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges),By Region, and Forecast till 2030.

Report ID : AMR1004241 | Industries : Healthcare | Published On :December 2023 | Page Count : 210

Global Drug Screening Market

Global Drug Screening Market was valued at US$ 6.22 Billion in 2022 and is estimated to reach US$ 22.28 Billion in 2030, exhibiting a CARG of 17.30% during the forecast period 2023 to 2030.
Global Drug Screening Market defined as” the technical procedure that involves evaluating samples such as hair, urine, oral secretions, breath, and other substances. Drug screening is a technique for detecting drugs or chemical compounds in the human body. Hospitals, drug testing centres, pain management centres, and law enforcement organisations all use this method. Drug testing is also done on employees and athletes by firms and organisations to check for drug usage.

Market Drivers

Increased drug and alcohol consumption, as well as the application of strict legislation requiring drug and alcohol testing, will all denote to the global drug screening market's rise in the near future. In addition, regulatory approvals and government backing in key markets are expected to fuel market growth in the coming years. On the contrary, restrictions on alcohol consumption in many Islamic countries and the prohibition of drug testing at workplaces in other locations are two major worries that could hinder the worldwide drug screening market's growth in the near future.

In emerging countries like China, rising rates of drug use among adults and teenagers have hampered employment and hampered the country's economic situation, which is anticipated to become a major factor contributing to market expansion. In addition, non-profit organisations and the government focus their efforts on funding drug screening programs, thereby improving drug screening technologies. Despite the industry's rapid growth, certain governmental and social decisions may constrain its expansion. Political policies, such as the restriction of alcohol consumption in some countries, could have a negative impact in the near future. COVID-19 has caused substantial disruptions in global economic and corporate activities, and it is expected to have a temporary negative impact on the global drug screening market.

Market Restraints

Major factors such as workplace prohibitions against drug and alcohol testing in some locations, employee privacy violations, and the need for physician approval for drug testing may limit market growth to some extent. Increased alcohol prohibition in some countries, as well as specificity difficulties with breathalyzers, will pose additional.
Prohibitions in various countries may hinder the adoption of drug & alcohol testing in these markets, thus restraining overall market growth to a certain extent.

Recent Development

Select Health of South Carolina and Quest Diagnostics came to an agreement in August 2021 to increase members' access to diagnostics information services and broaden Select Health's laboratory network for Medicaid and Medicare-Medicaid dual-eligible enrollees.
Psychemedics Corporation unveiled a vaping panel in May 2020 to identify marijuana, CBD, and nicotine use. This test offers a tool for businesses and schools to identify the use of these drugs by any method, including smoking or using electronic cigarettes.

Market Segmentation

Global Drug Screening market is segmented into By Product & Service, By sample, By end user, By Country. By Product & Service the market is segmented into (Drug Screening Product, Analytical Instruments, Rapid Testing Devices, Oral Fluid Testing Devices, Consumables, Drug Screening Service). By Sample market is segmented into (Urine Samples, Breath Samples, Fluid Samples, Hair
Samples, Other Samples). By End User market is segmented into (Drug Testing Laboratories Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers Individual Users, Pain Management Centers, Schools and Colleges).

Regional Analysis

Global Drug Screening Market is segmented into five regions such as North America, Europe, Asia Pacific, Latin America, and MEA. North America was the largest regional segment of the overall market with a share of 48.2%, followed by Europe.

Key Players

Key companies across the Drug Screening Market include Biotech (US), Omega Laboratories (US), Drägerwerk (Germany), Thermo Fisher Scientific (US), Alfa Scientific Designs (US), OraSure Technologies (US), Abbott Laboratories (US), Quest Diagnostics (US), LabCorp (US).

Market Taxonomy

By Product & Service
• Drug Screening Product
• Analytical Instruments
• Breathalyzers
• Fuel Cell Breathalyzer
• Semiconductor Breathalyzer
• Other Breathalyzers
• Immunoassay Analyzer
• Chromatography Instruments
• Rapid Testing Devices
• Urine Testing Devices
• Drug Testing Cups
• Dip Cards
• Drug Testing Cassetts
• Oral Fluid Testing Devices
• Consumables
• Assay Kits
• Sample Collection Devices
• Calibrators & Controls
• Other Consumables
• Drug Screening Service
By Sample Type
• Urine Samples
• Breath Samples
• Fluid Samples
• Hair Samples
• Other Samples
By End User
• Drug Testing Laboratories
• Workplaces
• Criminal Justice and Law Enforcement Agencies
• Hospitals
• Drug Treatment Centers
• Individual Users
• Pain Management Centers
• Schools and Colleges
By Region
• North America
o U.S.
o Canada
o Mexico
• Latin America
o Brazil
o Argentina
o Colombia
o Peru
o Chile
o Venezuela
o Rest of Latin America
• Europe
o Germany
o France
o UK
o Russia
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o New Zealand
o Singapore
o Malaysia
o Rest of Asia Pacific
• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest Middle East & Africa

Global Drug Screening Market

1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Drug Screening Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to Recent Energy Crisis
4.2.5 Cumulative Impact due to Nearing Economic Downturn
4.2.6 Post Covid-19 World Supply & Demand Conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Drug Screening Market, By Product & Service
5.1 Y-o-Y Growth Comparison, By Product & Service
5.2 Global Drug Screening Market Share Analysis, By Product & Service
5.3 Global Drug Screening Market Size and Forecast, By Product & Service
5.3.1 Drug Screening Product
5.3.2 Analytical Instruments
5.3.3 Breathalyzers
5.3.4 Fuel Cell Breathalyzer
5.3.5 Semiconductor Breathalyzer
5.3.6 Other Breathalyzers
5.3.7 Immunoassay Analyzer
5.3.8 Chromatography Instruments
5.3.9 Rapid Testing Devices
5.3.10 Urine Testing Devices
5.3.11 Drug Testing Cups
5.3.12 Dip Cards
5.3.13 Drug Testing Cassetts
5.3.14 Oral Fluid Testing Devices
5.3.15 Consumables
5.3.16 Assay Kits
5.3.17 Sample Collection Devices
5.3.18 Calibrators & Controls
5.3.19 Other Consumables
5.3.20 Drug Screening Service
6 Global Drug Screening Market, By Sample Type
6.1 Y-o-Y Growth Comparison, By Sample Type
6.2 Global Drug Screening Market Share Analysis, By Sample Type
6.3 Global Drug Screening Market Size and Forecast, By Sample Type
6.3.1 Urine Samples
6.3.2 Breath Samples
6.3.3 Fluid Samples
6.3.4 Hair Samples
6.3.5 Other Samples
7 Global Drug Screening Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Drug Screening Market Share Analysis, By End User
7.3 Global Drug Screening Market Size and Forecast, By End User
7.3.1 Drug Testing Laboratories
7.3.2 Workplaces
7.3.3 Criminal Justice and Law Enforcement Agencies
7.3.4 Hospitals
7.3.5 Drug Treatment Centers
7.3.6 Individual Users
7.3.7 Pain Management Centers
7.3.8 Schools and Colleges
8 Global Drug Screening Market, By Region
8.1 Global Drug Screening Market Share Analysis, By Region
8.2 Global Drug Screening Market Size and Forecast, By Region
8.3 Global Drug Screening Market Trends and Forecast, By Region
9 North America Drug Screening Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Drug Screening Market Size and Forecast, By Product & Service
9.3 North America Drug Screening Market Size and Forecast, By Sample Type
9.4 North America Drug Screening Market Size and Forecast, By End User
9.5 North America Drug Screening Market Size and Forecast, By Country
9.5.1 U.S.
9.5.1.1 Market Size and Forecast, By Product & Service
9.5.1.2 Market Size and Forecast, By Sample Type
9.5.1.3 Market Size and Forecast, By End User
9.5.2 Canada
9.5.2.1 Market Size and Forecast, By Product & Service
9.5.2.2 Market Size and Forecast, By Sample Type
9.5.2.3 Market Size and Forecast, By End User
9.5.3 Mexico
9.5.3.1 Market Size and Forecast, By Product & Service
9.5.3.2 Market Size and Forecast, By Sample Type
9.5.3.3 Market Size and Forecast, By End User
10 Europe Drug Screening Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Drug Screening Market Size and Forecast, By Product & Service
10.3 Europe Drug Screening Market Size and Forecast, By Sample Type
10.4 Europe Drug Screening Market Size and Forecast, By End User
10.5 Europe Drug Screening Market Size and Forecast, By Country
10.5.1 Germany
10.5.1.1 Market Size and Forecast, By Product & Service
10.5.1.2 Market Size and Forecast, By Sample Type
10.5.1.3 Market Size and Forecast, By End User
10.5.2 France
10.5.2.1 Market Size and Forecast, By Product & Service
10.5.2.2 Market Size and Forecast, By Sample Type
10.5.2.3 Market Size and Forecast, By End User
10.5.3 UK
10.5.3.1 Market Size and Forecast, By Product & Service
10.5.3.2 Market Size and Forecast, By Sample Type
10.5.3.3 Market Size and Forecast, By End User
10.5.4 Russia
10.5.4.1 Market Size and Forecast, By Product & Service
10.5.4.2 Market Size and Forecast, By Sample Type
10.5.4.3 Market Size and Forecast, By End User
10.5.5 Italy
10.5.5.1 Market Size and Forecast, By Product & Service
10.5.5.2 Market Size and Forecast, By Sample Type
10.5.5.3 Market Size and Forecast, By End User
10.5.6 Spain
10.5.6.1 Market Size and Forecast, By Product & Service
10.5.6.2 Market Size and Forecast, By Sample Type
10.5.6.3 Market Size and Forecast, By End User
10.5.7 Rest of Europe
10.5.7.1 Market Size and Forecast, By Product & Service
10.5.7.2 Market Size and Forecast, By Sample Type
10.5.7.3 Market Size and Forecast, By End User
11 Asia Pacific Drug Screening Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Drug Screening Market Size and Forecast, By Product & Service
11.3 Asia Pacific Drug Screening Market Size and Forecast, By Sample Type
11.4 Asia Pacific Drug Screening Market Size and Forecast, By End User
11.5 Asia Pacific Drug Screening Market Size and Forecast, By Country
11.5.1 China
11.5.1.1 Market Size and Forecast, By Product & Service
11.5.1.2 Market Size and Forecast, By Sample Type
11.5.1.3 Market Size and Forecast, By End User
11.5.2 Japan
11.5.2.1 Market Size and Forecast, By Product & Service
11.5.2.2 Market Size and Forecast, By Sample Type
11.5.2.3 Market Size and Forecast, By End User
11.5.3 India
11.5.3.1 Market Size and Forecast, By Product & Service
11.5.3.2 Market Size and Forecast, By Sample Type
11.5.3.3 Market Size and Forecast, By End User
11.5.4 South Korea
11.5.4.1 Market Size and Forecast, By Product & Service
11.5.4.2 Market Size and Forecast, By Sample Type
11.5.4.3 Market Size and Forecast, By End User
11.5.5 Australia
11.5.5.1 Market Size and Forecast, By Product & Service
11.5.5.2 Market Size and Forecast, By Sample Type
11.5.5.3 Market Size and Forecast, By End User
11.5.6 New Zealand
11.5.6.1 Market Size and Forecast, By Product & Service
11.5.6.2 Market Size and Forecast, By Sample Type
11.5.6.3 Market Size and Forecast, By End User
11.5.7 Singapore
11.5.7.1 Market Size and Forecast, By Product & Service
11.5.7.2 Market Size and Forecast, By Sample Type
11.5.7.3 Market Size and Forecast, By End User
11.5.8 Malaysia
11.5.8.1 Market Size and Forecast, By Product & Service
11.5.8.2 Market Size and Forecast, By Sample Type
11.5.8.3 Market Size and Forecast, By End User
11.5.9 Rest of Asia
11.5.9.1 Market Size and Forecast, By Product & Service
11.5.9.2 Market Size and Forecast, By Sample Type
11.5.9.3 Market Size and Forecast, By End User
12 Latin America Drug Screening Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Drug Screening Market Size and Forecast, By Product & Service
12.3 Latin America Drug Screening Market Size and Forecast, By Sample Type
12.4 Latin America Drug Screening Market Size and Forecast, By End User
12.5 Latin America Drug Screening Market Size and Forecast, By Country
12.5.1 Brazil
12.5.1.1 Market Size and Forecast, By Product & Service
12.5.1.2 Market Size and Forecast, By Sample Type
12.5.1.3 Market Size and Forecast, By End User
12.5.2 Argentina
12.5.2.1 Market Size and Forecast, By Product & Service
12.5.2.2 Market Size and Forecast, By Sample Type
12.5.2.3 Market Size and Forecast, By End User
12.5.3 Colombia
12.5.3.1 Market Size and Forecast, By Product & Service
12.5.3.2 Market Size and Forecast, By Sample Type
12.5.3.3 Market Size and Forecast, By End User
12.5.4 Peru
12.5.4.1 Market Size and Forecast, By Product & Service
12.5.4.2 Market Size and Forecast, By Sample Type
12.5.4.3 Market Size and Forecast, By End User
12.5.5 Chile
12.5.5.1 Market Size and Forecast, By Product & Service
12.5.5.2 Market Size and Forecast, By Sample Type
12.5.5.3 Market Size and Forecast, By End User
12.5.6 Venezuela
12.5.6.1 Market Size and Forecast, By Product & Service
12.5.6.2 Market Size and Forecast, By Sample Type
12.5.6.3 Market Size and Forecast, By End User
12.5.7 Rest of Latin America
12.5.7.1 Market Size and Forecast, By Product & Service
12.5.7.2 Market Size and Forecast, By Sample Type
12.5.7.3 Market Size and Forecast, By End User
13 Middle East Drug Screening Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Drug Screening Market Size and Forecast, By Product & Service
13.3 Middle East Drug Screening Market Size and Forecast, By Sample Type
13.4 Middle East Drug Screening Market Size and Forecast, By End User
13.5 Middle East Drug Screening Market Size and Forecast, By Country
13.5.1 Saudi Arabia
13.5.1.1 Market Size and Forecast, By Product & Service
13.5.1.2 Market Size and Forecast, By Sample Type
13.5.1.3 Market Size and Forecast, By End User
13.5.2 UAE
13.5.2.1 Market Size and Forecast, By Product & Service
13.5.2.2 Market Size and Forecast, By Sample Type
13.5.2.3 Market Size and Forecast, By End User
13.5.3 Egypt
13.5.3.1 Market Size and Forecast, By Product & Service
13.5.3.2 Market Size and Forecast, By Sample Type
13.5.3.3 Market Size and Forecast, By End User
13.5.4 Kuwait
13.5.4.1 Market Size and Forecast, By Product & Service
13.5.4.2 Market Size and Forecast, By Sample Type
13.5.4.3 Market Size and Forecast, By End User
13.5.5 South Africa
13.5.5.1 Market Size and Forecast, By Product & Service
13.5.5.2 Market Size and Forecast, By Sample Type
13.5.5.3 Market Size and Forecast, By End User
13.5.6 Rest of Middle East & Africa
13.5.6.1 Market Size and Forecast, By Product & Service
13.5.6.2 Market Size and Forecast, By Sample Type
13.5.6.3 Market Size and Forecast, By End User
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Biotech (US)
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Omega Laboratories (US)
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Drägerwerk (Germany)
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Thermo Fisher Scientific (US)
15.4.1 Overview
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Alfa Scientific Designs (US)
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 OraSure Technologies (US)
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Abbott Laboratories (US)
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Quest Diagnostics (US)
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 LabCorp (US)
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Clinical Reference Laboratory Inc. (U.S.)
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies